Four-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT II trial
Scot Garg, Patrick W. Serruys, Karine Miquel-Hebert, on behalf of the SPIRIT II InvestigatorsVolume:
77
Year:
2011
Language:
english
Pages:
6
DOI:
10.1002/ccd.22770
File:
PDF, 219 KB
english, 2011